Cardiovascular Disease
More diabetes treatment adds life years, reduces costs in low-, middle-income nations
Increasing treatment and control of diabetes for people living in low- or middle-income countries could reduce risks for complications and, in turn, save health care dollars, according to findings from a microsimulation.
JAK inhibitors tied to increased CV, cancer risk in RA: 'But is it clinically meaningful?'
Janus kinase inhibitors are associated with numerical, but not statistically significant, risks for adverse cardiovascular events and malignancy, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.
SPRINT results not driven by reduced HF risk; benefits of intensive BP lowering unchanged
The benefits of an intensive BP-lowering strategy to less than 120 mm Hg, as assessed in the SPRINT trial, were consistent even with the exclusion of HF-related events, according to data published in Hypertension.
Curiosity prevails: A conversation with Robert H. Eckel, MD
For Robert H. Eckel, MD, a desire to learn about the underlying mechanisms driving disease sparked an early interest in what would become groundbreaking research in the fields of lipid metabolism and cardiometabolic health.
Plant-based diets, time-restricted eating provide cardiometabolic benefits
Eating a balanced, plant-based diet and practicing time-restricted eating can provide cardiometabolic benefits and may reduce the risk for cardiovascular disease, according to a speaker at the Heart in Diabetes CME Conference.
‘Cultural competence’ key to reduce cardiometabolic risk among South Asian subgroups
South Asian adults develop cardiovascular disease approximately a decade earlier than people of other ethnicities, and the multifactorial causes of premature risk show more preventive work is needed, according to a speaker.
Pharmacological BP reduction effective for lowering CV event risk regardless of age
Lowering BP through medication reduced risk for CV events across almost all age groups, suggesting age-related BP thresholds should be removed from guidelines, researchers reported at the European Society of Cardiology Congress.
AHA issues recommendations for patients with CVD planning high-altitude activities
Because sudden cardiac death can occur in patients with CVD traveling to higher altitudes, experts recommended in a new American Heart Association scientific statement that patients with CVD consult a physician before travel.
New, worsening HF most common causes of type 2 MI
New and worsening chronic HF were the most common causes of type 2 MI, and 20% of patients with a type 2 MI event were readmitted for HF within 1 year, according to data published in the Journal of the American Heart Association.
Human, exendin-based GLP-1 receptor agonists similarly reduce CV, renal risk in diabetes
A pooled study assessing trials of eight GLP-1 receptor agonists showed all reduce risk for a combined endpoint of major adverse cardiovascular events, regardless of structural homology to human GLP-1, as well as individual CV components.